| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Andrew J. Mills is Director at MDLN. Andrew J. Mills's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $88.2M at current prices.
Net of sales, the MDLN filings show accumulation of 2,586,206 shares.
Andrew J. Mills has 1 Form 4 filing on record in December 2025, as Director at Medline (MDLN), 2025.
The 3 reported transactions were 1 stock award, 1 open-market purchase and 1 option or other derivative award.
Counted by filing, the open-market trades come to 1 purchase worth about $75.0M and no sales.
The only open-market purchase was 2,586,206 shares of MDLN at an average $29.00 on December 18, 2025, about $75.0M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | MDLN Medline Inc. | Director | Buy | 2,586,206 | $29.00 | $74,999,974.00 | New | +7.0% | - |